B

BBIO

BBIO

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
BBIO Live QuoteReal-time
$78.18
+$10.44(+15.41%)1M
Day Range$77.80 – $79.88
Open$78.41
Previous Close$78.01
Volume2.16M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$15.23B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-3.03
Price to Book123.7
Dividend Yield0.65%
Beta (Volatility)0.94
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $78.18 (51%)
Low: $62.50High: $93.42
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$107.00-28.7% upside

Insider Buys

2

$55K

Insider Sales

73

$869.30M

Total Volume

$869.36M

75 transactions

Net Activity

$869.25M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
15CONFIDENCE

Sentiment Rating

Heavy Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
K
1

Kkr Genetic Disorder L.P.

10%

0 buys2 sells

$402.96M total

V
2

Viking Global Investors LP

10%

0 buys2 sells

$260.99M total

K
3

Kumar Neil

CEO

0 buys26 sells

$108.83M total

C
4

Cook Jennifer E.

Dir

0 buys3 sells

$21.92M total

M
5

McCormick Frank

Dir

0 buys4 sells

$21.67M total

Trading History
BBIO insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 30, 2026

3 weeks ago

Apuli Maricel

Chief Accounting Officer

C-Level
Sell2.0K$72.85$146K

Sep 17, 2026

2 months ago

Kumar Neil

CEO

CEO
Sell10.0K$69.08$691K

Aug 18, 2026

3 months ago

Kumar Neil

CEO

CEO
Sell45.0K$82.86$3.73M

Jul 30, 2026

3 months ago

Apuli Maricel

Chief Accounting Officer

C-Level
Sell2.0K$80.06$160K

Jul 9, 2026

4 months ago

Ellis Andrea

Dir

Director
Sell17.2K$84.00$1.44M

Jul 9, 2026

4 months ago

Cook Jennifer E.

Dir

Director
Sell148.6K$88.54$13.16M

Jun 23, 2026

5 months ago

Cook Jennifer E.

Dir

Director
Sell39.4K$69.92$2.75M

Jun 22, 2026

5 months ago

Valantine Hannah

Dir

Director
Sell5.0K$68.25$342K

Jun 15, 2026

5 months ago

Cook Jennifer E.

Dir

Director
Sell90.2K$66.62$6.01M

Jun 4, 2026

5 months ago

Kumar Neil

CEO

CEO
Sell80.0K$67.67$5.41M

May 21, 2026

6 months ago

Kumar Neil

CEO

CEO
Sell26.1K$69.44$1.81M

May 18, 2026

6 months ago

Trimarchi Thomas

Pres, CFO

CFO
Sell13.7K$65.08$888K

May 15, 2026

6 months ago

Scott Randal W.

Dir

Director
Sell10.0K$67.15$671K

May 7, 2026

6 months ago

Kumar Neil

CEO

CEO
Sell80.0K$67.40$5.39M

Apr 30, 2026

6 months ago

Apuli Maricel

Chief Accounting Officer

C-Level
Sell2.0K$71.58$143K

Apr 9, 2026

7 months ago

Kumar Neil

CEO

CEO
Sell80.0K$74.61$5.97M

Mar 12, 2026

8 months ago

Kumar Neil

CEO

CEO
Sell80.0K$68.76$5.50M

Mar 10, 2026

8 months ago

Valantine Hannah

Dir

Director
Sell8.7K$72.00$624K

Mar 4, 2026

8 months ago

Ellis Andrea

Dir

Director
Sell64.9K$64.87$4.21M

Feb 27, 2026

8 months ago

Valantine Hannah

Dir

Director
Sell25.5K$67.41$1.72M

Feb 26, 2026

8 months ago

Apuli Maricel

Chief Accounting Officer

C-Level
Sell2.0K$66.00$132K

Feb 19, 2026

9 months ago

Kumar Neil

CEO

CEO
Sell28.1K$71.39$2.00M

Feb 17, 2026

9 months ago

Apuli Maricel

Chief Accounting Officer

C-Level
Sell510$74.31$38K

Feb 17, 2026

9 months ago

Trimarchi Thomas

Pres, CFO

CFO
Sell13.6K$74.72$1.02M

Feb 17, 2026

9 months ago

Scott Randal W.

Dir

Director
Sell10.0K$75.46$755K

Feb 10, 2026

9 months ago

Kumar Neil

CEO

CEO
Sell80.0K$71.86$5.75M

Jan 8, 2026

10 months ago

Kumar Neil

CEO

CEO
Sell80.0K$75.54$6.04M

Dec 15, 2025

11 months ago

Kumar Neil

CEO

CEO
Sell30.0K$74.64$2.24M

Dec 8, 2025

11 months ago

Apuli Maricel

Chief Accounting Officer

C-Level
Sell2.0K$74.26$149K

Dec 4, 2025

11 months ago

Kumar Neil

CEO

CEO
Sell80.0K$73.86$5.91M

Nov 20, 2025

12 months ago

Kumar Neil

CEO

CEO
Sell26.2K$65.84$1.72M

Nov 17, 2025

12 months ago

Lo Andrew

Dir

Director
Sell95.6K$66.11$6.32M

Nov 17, 2025

12 months ago

Scott Randal W.

Dir

Director
Sell10.0K$66.65$666K

Nov 17, 2025

12 months ago

Trimarchi Thomas

Pres, CFO

CFO
Sell16.9K$66.46$1.13M

Nov 12, 2025

12 months ago

Valantine Hannah

Dir

Director
Sell25.5K$66.07$1.68M

Nov 6, 2025

12 months ago

Kumar Neil

CEO

CEO
Sell80.0K$62.29$4.98M

Nov 6, 2025

12 months ago

Daniels Ronald J

Dir

Director
Sell61.0K$63.72$3.89M

Oct 29, 2025

12 months ago

McCormick Frank

Dir

Director
Sell198.4K$66.58$13.21M

Oct 27, 2025

12 months ago

McCormick Frank

Dir

Director
Sell1.6K$65.00$107K

Oct 8, 2025

13 months ago

Kumar Neil

CEO

CEO
Sell80.0K$54.79$4.38M

Sep 5, 2025

14 months ago

McCormick Frank

Dir

Director
Sell74.0K$53.16$3.93M

Sep 4, 2025

14 months ago

Kumar Neil

CEO

CEO
Sell80.0K$52.20$4.18M

Aug 21, 2025

15 months ago

Trimarchi Thomas

Pres, CFO

CFO
Sell42.2K$49.48$2.09M

Aug 20, 2025

15 months ago

Kumar Neil

CEO

CEO
Sell26.2K$48.82$1.28M

Aug 18, 2025

15 months ago

Trimarchi Thomas

Pres, CFO

CFO
Sell17.4K$50.23$872K

Aug 8, 2025

15 months ago

Homcy Charles J

Dir

Director
Sell300.0K$46.37$13.91M

Aug 7, 2025

15 months ago

Apuli Maricel

Chief Accounting Officer

C-Level
Sell1.0K$45.44$45K

Aug 7, 2025

15 months ago

Kumar Neil

CEO

CEO
Sell80.0K$45.84$3.67M

Aug 5, 2025

15 months ago

Ellis Andrea

Dir

Director
Sell17.2K$49.00$841K

Jul 1, 2025

16 months ago

Kumar Neil

CEO

CEO
Sell80.0K$42.63$3.41M

Jun 27, 2025

17 months ago

Viking Global Investors LP

10%

10% Owner
Sell3.50M$44.00$154.00M

Jun 26, 2025

17 months ago

Valantine Hannah

Dir

Director
Sell4.7K$44.05$207K

Dec 29, 2021

59 months ago

Valantine Hannah

Dir

Director
Buy1.8K$14.24$25K

Dec 28, 2021

59 months ago

Valantine Hannah

Dir

Director
Buy2.3K$12.84$30K

Jun 24, 2025

17 months ago

McCormick Frank

Dir

Director
Sell100.0K$44.23$4.42M

Jun 10, 2025

17 months ago

Valantine Hannah

Dir

Director
Sell4.3K$40.00$172K

May 19, 2025

18 months ago

Kumar Neil

CEO

CEO
Sell101.2K$33.38$3.38M

May 12, 2025

18 months ago

Kkr Genetic Disorder L.P.

10%

10% Owner
Sell6.00M$34.20$205.20M

May 2, 2025

18 months ago

Apuli Maricel

Chief Accounting Officer

C-Level
Sell1.0K$38.51$40K

May 2, 2025

18 months ago

Lo Andrew

Dir

Director
Sell100.0K$38.50$3.85M

Apr 22, 2025

19 months ago

Kumar Neil

CEO

CEO
Sell75.0K$34.11$2.56M

Apr 14, 2025

19 months ago

Ellis Andrea

Dir

Director
Sell10.0K$35.00$350K

Apr 1, 2025

19 months ago

Ellis Andrea

Dir

Director
Sell30.0K$34.05$1.02M

Mar 25, 2025

20 months ago

Kumar Neil

CEO

CEO
Sell75.0K$36.87$2.76M

Mar 6, 2025

20 months ago

Valantine Hannah

Dir

Director
Sell12.9K$32.58$420K

Mar 5, 2025

20 months ago

Kkr Genetic Disorder L.P.

10%

10% Owner
Sell6.00M$32.96$197.76M

Feb 25, 2025

21 months ago

Stephenson Brian C

CFO, Treasurer

CFO
Sell8.5K$33.19$282K

Feb 25, 2025

21 months ago

Kumar Neil

CEO

CEO
Sell75.0K$33.57$2.52M

Feb 19, 2025

21 months ago

Stephenson Brian C

Secretary, Treasurer, CFO

CFO
Sell4.1K$36.16$150K

Feb 19, 2025

21 months ago

Kumar Neil

CEO

CEO
Sell31.5K$36.14$1.14M

Jan 31, 2025

21 months ago

Viking Global Investors LP

10%

10% Owner
Sell3.07M$34.90$106.99M

Jan 28, 2025

22 months ago

Stephenson Brian C

Secretary, Treasurer, CFO

CFO
Sell68.0K$36.29$2.47M

Jan 28, 2025

22 months ago

Kumar Neil

CEO

CEO
Sell600.0K$36.31$21.79M

Nov 19, 2024

24 months ago

Kumar Neil

CEO

CEO
Sell27.4K$22.41$614K

Nov 19, 2024

24 months ago

Stephenson Brian C

Secretary, Treasurer, CFO

CFO
Sell4.2K$22.41$93K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
BBIO Buy Conviction0%
Industry Rank#452 of 569
Volume Contribution5.3%
Total Industry Activity$16.53B

BBIO has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. BBIO ranks #452 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for BBIO

Over the last 90 days, corporate insiders at BBIO (BBIO) engaged in a total of 75 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 73 were sales. The total volume of insider trading reached $869.36M.

The net insider activity for BBIO shows a net selling bias of $869.25M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Kkr Genetic Disorder L.P. (10%), who traded 6.00M shares valued at $205.20M on May 12, 2025.

Live Market News & Developments
Aggregated real-time headlines for BBIO (BBIO)
6 updates

BridgeBio Pharma, Inc. (BBIO) stock price, news, quote and history

Yahoo Finance UK19h ago

BridgeBio Pharma, Inc. (BBIO) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

BBIO: Director Neil Kumar proposes sale of 34,980 BridgeBio shares

QuantisnowYesterday

A family trust proposes selling 30,000 BridgeBio Pharma (BBIO) shares around Nov. 19, 2026.

Stock Titan14h ago

Palisade Bio Stock Price Forecast. Should You Buy PALI?

StockInvest.us2d ago

Windward Bio’s Stock Market Debut Reels In $225M for Better Biologic Drugs

MedCity News6d ago

FAQs About BBIO Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for BBIO.

Based on SEC Form 4 disclosures, the Insider Confidence Score for BBIO is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 2 purchases and 73 sales by company executives over the last 90 days.

The CEO Conviction Index for BBIO is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.